This clinical trial develops and tests a mobile application in improving symptoms, coping, and quality of life in patients with stage III-IV non-small cell lung cancer that cannot be removed by surgery (unresectable). Many people diagnosed with lung cancer experience challenging symptoms and increased stress. A mobile application may offer quality supportive care in an easily accessible manner.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04629300.
PRIMARY OBJECTIVES:
I. To develop a novel supportive care mobile app by adapting our existing mobile application (app) interventions in order to address the specific symptom management and coping needs of patients with advanced non-small cell lung cancer (NSCLC).
II. To examine the feasibility and acceptability a novel mobile app to improve symptoms, coping skills, and quality of life (QOL) in patients with advanced NSCLC.
III. To test the preliminary efficacy of a novel mobile app to improve symptoms, coping skills, and QOL in patients with advanced NSCLC.
EXPLORATORY OBJECTIVE:
I. To qualitatively explore patients' general perceptions of the supportive care mobile app and their overall satisfaction with the intervention by conducting qualitative interviews.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients use mobile app to complete intervention modules over 10 weeks.
GROUP II: Patients receive standard oncology care.
After completion of study, patients are followed up at 12 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorJoseph Greer
